¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2022³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãá°èÇмú´ëȸ (2ÀÏÂ÷) : 2022-03-05

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2022³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãá°èÇмú´ëȸ (2ÀÏÂ÷) : 2022-03-05
±³À°ÀÏÀÚ : 2022-03-05
±³À°Àå¼Ò : ºÎ»êBPEX  
±³À°ÁÖÁ¦ : 2022³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãá°èÇмú´ëȸ (2ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑ°©»ó¼±ÇÐȸ
´ã´çÀÚ : ÀÌÀçÀº
¿¬¶ôó : 02-743-0320  
À̸ÞÀÏ : office@thyroid.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, À̺ñÀÎÈÄ°ú, ¿µ»óÀÇÇаú, º´¸®°ú, ÇÙÀÇÇаú
Âü¼®¿¹»óÀοø : 250¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 7 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 120,000¿ø      
ºñ°í 1. Àü¹®ÀÇ/ÀϹÝÀÇ 1) Æò»ýȸ¿ø ¹× Á¤È¸¿ø(¿¬È¸ºñ ³³ºÎÀÚ) »çÀüµî·Ï 90,000¿ø, ÇöÀåµî·Ï 110,000¿ø, 2) ºñȸ¿ø »çÀüµî·Ï 100,000¿ø, ÇöÀåµî·Ï 120,000¿ø 2. Àü°øÀÇ/±ºÀÇ°ü/°øÁߺ¸°ÇÀÇ/°£È£»ç/±âÃÊÀÇÇÐÀÚ 1) Æò»ýȸ¿ø ¹× Á¤È¸¿ø(¿¬È¸ºñ ³³ºÎÀÚ) »çÀüµî·Ï 50,000¿ø, ÇöÀåµî·Ï 70,000¿ø, 2) ºñȸ¿ø »çÀüµî·Ï 70,000¿ø, ÇöÀåµî·Ï 90,000¿ø 3. ¸¸65¼¼ ÀÌ»óÀÎ Æò»ýȸ¿ø, Çкλý ¹× ÀÇÀü¿ø Çлý : ¹«·á      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 08:30~08:50 Role of Serum TSH in Active Surveillance of PTMC  ±èÇýÀÎ(¼º±Õ°üÀÇ´ë ³»°ú) 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 08:50~09:10 Tumor Volume Doubling Time in Active Surveillance of PTMC  ±è¿ø¹è(¿ï»êÀÇ´ë ³»°ú) 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 09:10~09:30 Interim Analysis of MAeSTro  ÀÌÀº°æ(±¹¸³¾Ï¼¾ÅÍ ³»°ú) 
Åä·Ð 03-05 À̺¥Æ®È¦A&B 09:30~09:40 ÅäÀÇ  () 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 09:40~10:00 Characterizing Dedifferentiation of Thyroid Cancer by Single Cell RNA Seqencing  ¹ÚÁöȯ(GIST) 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 10:00~10:20 Diagnositc Approach in Thyroid Disease using Biometric Wearable Devices  ¹®ÀçÈÆ(¼­¿ïÀÇ´ë ³»°ú) 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 10:20~10:40 Artificial intelligence in Diagnosis of Thyroid Cancer   ÇÏÀºÁÖ(¾ÆÁÖÀÇ´ë ¿µ»óÀÇÇаú) 
Åä·Ð 03-05 À̺¥Æ®È¦A&B 10:40~10:50 ÅäÀÇ  () 
È޽Ġ03-05 À̺¥Æ®È¦A&B 10:50~11:10 Coffee Break  () 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 11:10~12:10 Diagnostic, Prognostic and Predictive Factors in Differentiated Thyroid Carcinomas: From Morphology to Biomarker Studies  Ozgur Mete(Toronto General Hospital: University Health Network Canada) 
±âŸ 03-05 À̺¥Æ®È¦A&B 12:10~12:40 ÃÑȸ  () 
½Ä»ç 03-05 À̺¥Æ®È¦A&B 12:40~13:40 Á¡½É ½Ä»ç  () 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 13:40~14:20 ¹æ»ç¼º¿ä¿Àµå Ä¡·á¿Í 2Â÷¾Ï  ÀÌÀçÅÂ(°æºÏÀÇ´ë ÇÙÀÇÇаú) 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 14:20~14:40 NIRAF in Thyroid Surgery  ÀÌ°­´ë(°í½ÅÀÇ´ë À̺ñÀÎÈÄ°ú) 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 14:40~15:00 New Imaging Techniques (Photoaccoustic Image, Laser Speckle, Next USG)  ±èÁö¼ö(ºÎ»ê´ë ³ª³ë°úÇбâ¼ú´ë) 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 15:00~15:20 Percutaneous Neuromonitoring  À̺´ÁÖ(ºÎ»êÀÇ´ë À̺ñÀÎÈÄ°ú) 
Åä·Ð 03-05 À̺¥Æ®È¦A&B 15:20~15:30 ÅäÀÇ  () 
È޽Ġ03-05 À̺¥Æ®È¦A&B 15:30~15:50 Coffee Break  () 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 15:50~16:50 Serial Studies of Apatinib in Patients with Radioiodine Refractory Thyroid Cancer  Yansong Lin(Peking Union Medical College Hospital China) 
±âŸ 03-05 À̺¥Æ®È¦A&B 16:50~17:50 Topic Highlight  () 
±âŸ 03-05 À̺¥Æ®È¦D 08:30~09:40 Free Paper 3  () 
±âŸ 03-05 À̺¥Æ®È¦D 09:40~10:50 Free Paper 4  () 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦D 14:20~14:40 °©»ó¼± ÃÊÀ½ÆÄ ±Þ¿©È­  ÇѼö¿¬(¼º±Õ°üÀÇ´ë ¿µ»óÀÇÇаú) 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦D 14:40~15:00 ¼ö¼úÀå CCTV - º´ÇùÀÔÀå  ¼ÛÀçÂù(´ëÇѺ´¿øÇùȸ ºÎȸÀå) 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦D 15:00~15:20 ¼ö¼úÀå CCTV - ÀÇÇùÀÔÀå  ±èÁ¾¹Î(´ëÇÑÀÇ»çÇùȸ º¸ÇèÀÌ»ç) 
Åä·Ð 03-05 À̺¥Æ®È¦D 15:20~15:30 ÅäÀÇ  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2022³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãá°èÇмú´ëȸ (2ÀÏÂ÷) : 2022-03-05""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2022³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãá°è¿¬¼ö°­Á : 2022-03-05
´ÙÀ½±Û ´ëÇÑ°©»ó¼±ÇÐȸ °©»ó¼± ÃÊÀ½ÆÄ Hands-On Course : 2022-03-04
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20775 ¼­¿ï 2024³â °áÇÙ°ü¸®±³À° 1±â(1ÀÏÂ÷) : 2024-06-13 0 2 2024-05-27
20774 ºÎ»ê (¿Â¶óÀÎ) ´ëÇÑÀ̺ñÀÎÈÄ°úÇÐȸ ºÎ»ê¡¤¿ï»ê¡¤°æ³² ÁöºÎȸ 2024³â 06¿ù Çмú´ëȸ : 2024-06-13 0 4 2024-05-27
20773 ´ëÀü 2024 Á¦40ȸ ´ëÇѼҾƿܰúÇÐȸ Ãá°èÇмú´ëȸ ¹× 40Áֳ⠱â³äÇà»ç(1ÀÏÂ÷) : 2024-06-13 0 2 2024-05-27
20772 ´ë±¸ 2024 Á¦2Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ ´ë±¸°æºÏÁöºÎÇÐȸ : 2024-06-13 0 6 2024-05-27
20771 ¼­¿ï ´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ 2024³â Á¦19Â÷ Çмú´ëȸ (1ÀÏÂ÷) : 2024-06-13 0 10 2024-05-27
20770 ¼­¿ï 2024 ´ëÇÑÈ­»óÇÐȸ Çмú´ëȸ(1ÀÏÂ÷) : 2024-06-13 0 3 2024-05-27
20769 ¼­¿ï 2024³â ±Ýõ±¸ÀÇ»çȸ 1Â÷ ¿¬¼ö±³À°(¿ì¿ïÁõ ¾àÁ¦, ÇǺÎÁúȯ, CBC¿Í LFT, À§¿°) : 2024-06-12 0 1 2024-05-27
20768 ¼­¿ï 2024 Á¦3ȸ ÀÌ°ÇÈñ ¼Ò¾Æ¾Ï¡¤Èñ±ÍÁúȯ ±Øº¹»ç¾÷ ¿¬±¸ÀÚ SKILL-UP Workshop : 2024-06-12 0 1 2024-05-27
20767 °æ±â ´ëÇÑÇǺΰúÇÐȸ Á¦78Â÷ °æ±âÁöºÎȸ ÇмúÁý´ãȸ : 2024-06-11 0 1 2024-05-27
20766 ±¤ÁÖ Á¦180Â÷ ´ëÇѼҾÆû¼Ò³â°úÇÐȸ ±¤ÁÖ¡¤Àü³²Áöȸ ÇмúÁý´ãȸ : 2024-06-11 0 6 2024-05-27
20765 ºÎ»ê ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ºÎ»ê,¿ï»ê,°æ³²Áöȸ - Á¦362Â÷ ¿ù·ÊÇмúȸ : 2024-06-11 0 10 2024-05-27
20764 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ±âº»±³À° : 2024-06-11 0 5 2024-05-27
20763 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ(ÀÇ»ç) ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ½ÉÈ­±³À° : 2024-06-11 0 7 2024-05-27
20762 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼҾÆÀÀ±ÞÀÇÇÐȸ Á¦ 32ȸ Á¤±â Áý´ãȸ : 2024-06-10 0 9 2024-05-27
20761 ¼­¿ï °í·Á´ëÇб³±¸·Îº´¿ø Á¦16ȸ KOALA Symposium 2024 : 2024-06-09 0 1 2024-05-27
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷